Search research articles
Contact Us
Filters
Showing results (31-40 of 73) with videos related to
Page
of 8
Sort By:
Journal for Immunotherapy of Cancer
|
July 20, 2024
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee
Anne Monette, Sarah Warren, J Carl Barrett, et al.
Cancer Cell
|
September 12, 2023
Tumor dynamics in patients with solid tumors treated with pembrolizumab beyond disease progression
Brian G Topp, Madhav Channavazzala, Kapil Mayawala, et al.
Gynecologic Oncology Reports
|
February 11, 2022
Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancer
Rami Vanguri, Jamal Benhamida, Jonathan H Young, et al.
Journal of the American Society of Nephrology : JASN
|
December 5, 2009
The ubiquitin-like protein FAT10 mediates NF-kappaB activation
Pengfei Gong, Allon Canaan, Bin Wang, et al.
Journal for Immunotherapy of Cancer
|
February 1, 2022
Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors
Razvan Cristescu, Deepti Aurora-Garg, Andrew Albright, et al.
Immunity
|
January 5, 2022
Germline HLA landscape does not predict efficacy of pembrolizumab monotherapy across solid tumor types
Aparna Chhibber, Lingkang Huang, Hong Zhang, et al.
Cell Reports
|
April 12, 2018
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes
Alexander Solovyov, Nicolas Vabret, Kshitij S Arora, et al.
Cancer Immunology Research
|
December 14, 2016
Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade
Tavi Nathanson, Arun Ahuja, Alexander Rubinsteyn, et al.
JCO Precision Oncology
|
September 11, 2020
Computed Tomography-Derived Radiomic Metrics Can Identify Responders to Immunotherapy in Ovarian Cancer
Yuki Himoto, Harini Veeraraghavan, Junting Zheng, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 25, 2021
Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition
Jianda Yuan, Anuradha Khilnani, Joshua Brody, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 73) with videos related to
Sort By:
Page
of 8
Journal for Immunotherapy of Cancer
|
July 20, 2024
Biomarker development for PD-(L)1 axis inhibition: a consensus view from the SITC Biomarkers Committee
Anne Monette, Sarah Warren, J Carl Barrett, et al.
Cancer Cell
|
September 12, 2023
Tumor dynamics in patients with solid tumors treated with pembrolizumab beyond disease progression
Brian G Topp, Madhav Channavazzala, Kapil Mayawala, et al.
Gynecologic Oncology Reports
|
February 11, 2022
Understanding the impact of chemotherapy on the immune landscape of high-grade serous ovarian cancer
Rami Vanguri, Jamal Benhamida, Jonathan H Young, et al.
Journal of the American Society of Nephrology : JASN
|
December 5, 2009
The ubiquitin-like protein FAT10 mediates NF-kappaB activation
Pengfei Gong, Allon Canaan, Bin Wang, et al.
Journal for Immunotherapy of Cancer
|
February 1, 2022
Tumor mutational burden predicts the efficacy of pembrolizumab monotherapy: a pan-tumor retrospective analysis of participants with advanced solid tumors
Razvan Cristescu, Deepti Aurora-Garg, Andrew Albright, et al.
Immunity
|
January 5, 2022
Germline HLA landscape does not predict efficacy of pembrolizumab monotherapy across solid tumor types
Aparna Chhibber, Lingkang Huang, Hong Zhang, et al.
Cell Reports
|
April 12, 2018
Global Cancer Transcriptome Quantifies Repeat Element Polarization between Immunotherapy Responsive and T Cell Suppressive Classes
Alexander Solovyov, Nicolas Vabret, Kshitij S Arora, et al.
Cancer Immunology Research
|
December 14, 2016
Somatic Mutations and Neoepitope Homology in Melanomas Treated with CTLA-4 Blockade
Tavi Nathanson, Arun Ahuja, Alexander Rubinsteyn, et al.
JCO Precision Oncology
|
September 11, 2020
Computed Tomography-Derived Radiomic Metrics Can Identify Responders to Immunotherapy in Ovarian Cancer
Yuki Himoto, Harini Veeraraghavan, Junting Zheng, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 25, 2021
Current strategies for intratumoural immunotherapy - Beyond immune checkpoint inhibition
Jianda Yuan, Anuradha Khilnani, Joshua Brody, et al.
Page
of 8